Lucira Health, Inc. develops disposable Point-of-Care molecular tests for rapid and accurate diagnosis of infectious disease. By eliminating centralized instrument-based testing, Lucira Health's products will empower physicians to be nimbler and more informed with on-the-spot diagnostic information.
Market
Infectious Disease Diagnostics
Location
Emeryville,
California,
USA
Coinvestors
Data Collective, Eclipse Ventures, ShangBay Capital, Sunstone Management, Y Combinator